Prevalence and predictors of arthralgia after initiation of vedolizumab in patients with inflammatory bowel disease: a retrospective cohort study.

Kokkotis G., Zampeli E., Tzouvala M., Giotis I., Orfanos P., Benetou V., Stoupaki M., Leontidis N., Leonidakis N., Kitsou V., Gaki A., Lagiou P., Michopoulos S. and Bamias G.

Eur J Gastroenterol Hepatol 2023; 35(4): 371-375.

https://doi.org/10.1097/meg.0000000000002527